Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06356142 · ClinicalTrials.gov registry record · Early Phase 1
The Effects of Palmar Cooling on Repeated Sprinting Ability
A Early Phase 1 study, sponsored by University of Mississippi Medical Center.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 15
- Enrollment target
NCT06356142 is a Early Phase 1 study that has completed, run by University of Mississippi Medical Center. The registered enrollment target is 15 participants.
The verdict
NCT06356142, a Early Phase 1 study, has completed, sponsored by University of Mississippi Medical Center.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 15 participants
- Enrollment target
Study Summary
Repeated sprinting ability is key for athletic performance in a variety of sport settings. Significant degradations in work output (i.e. fatigue) have been shown to develop after just one sprinting bout1. This pilot study aims to investigate the effects that noninvasive transient temperature manipulation has on an individual's ability to perform repeated sprints. The investigators aim to enroll 90 healthy individuals, 18-30 years of age. Participants will be randomized into two groups (Group A, and B). All groups will perform a ten-minute warm-up followed by two minutes of rest. Following the warm-up and rest period, all groups will participate in a series of five sprints, 60 meters in total length with two 180 degree changes in direction. Between sprints, participants will have 10 seconds rest. After the first series of five sprints participants will be given a 2-minute rest interval. Then participants will perform another series of five sprints followed by another 2-minute rest interval. During each rest interval, Group A will utilize a palmar cooling device. Group B will utilize a placebo version of the palmar cooling device. All sprints will be timed. Heart rate recovery will be measured during all rest breaks, and a rating of perceived exertion will be measured at the beginning and end of each resting interval. Delayed onset muscle soreness will be assessed 48 hours post sprinting, utilizing a visual analog scale.
Interventions
- DEVICE Palmar Cooling
- DEVICE Placebo Palmar Cooling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2024-06-28 |
| Est. Completion | 2024-06-28 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06356142
The ClinicalTrials.gov registry entry for NCT06356142 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Mississippi Medical Center, which has 96 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Palmar Cooling is the first listed.
NCT06356142 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06356142 about?
NCT06356142 is a clinical study titled "The Effects of Palmar Cooling on Repeated Sprinting Ability". Repeated sprinting ability is key for athletic performance in a variety of sport settings. Significant degradations in work output (i.e. fatigue) have been shown to develop after just one sprinting bout1. This pilot study aims to investigate the effects that noninvasive transient temperature manipul...
What is the current status of trial NCT06356142?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 15 participants. The study started on 2024-06-28. Estimated completion is 2024-06-28.
What interventions are being tested in trial NCT06356142?
The interventions under investigation include: Palmar Cooling (DEVICE), Placebo Palmar Cooling (DEVICE).
Who is sponsoring clinical trial NCT06356142?
This trial is sponsored by University of Mississippi Medical Center, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.